Factors contributing to excessive antimicrobial prescribing

Pharmacotherapy

Volumn 27, Issue 10 II, 2007, Pages

  Ebert, Steven C ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MERITER HOSPITAL   (United States)

Author keywords

Antibiotic; Antimicrobial; Methicillin resistant staphylococcus aureus; MRSA; Pathogen; Resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; DICLOXACILLIN; ERYTHROMYCIN; METICILLIN; NITROFURANTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; CLINICAL PRACTICE; CONFERENCE PAPER; ENTEROCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT EDUCATION; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 34948860644     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.10part2.126s     Document Type: Conference Paper

References (21)

1. European Surveillance of Antimicrobial Consumption. Programme of community action on the prevention of AIDS and certain other communicable diseases: final implementation report. Available from http://www.esac.ua.ac.be/ main.aspx7c=*ESAC2&n=24345. Accessed January 8, 2007.
2. Spiro DM, Tay KY, Arnold DH, et al. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA 2006;296:1235-41.
3. Fine MJ, Stone RA, Singer DE, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team (PORT) cohort study. Arch Intern Med 1999;159:970-80.
4. Singh N, Rogers P Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505-11.
5. Weber JT, Courvalin P. An emptying quiver: antimicrobial drugs and resistance. Emerg Infect Dis 2005;11:791-3.
6. Ernst EJ, Diekema DJ, BootsMiller BJ, et al. Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data? Diagn Microbiol Infect Dis 2004;49:141-5.
7. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;278: 901-4.
8. Macfarlane J, Holmes W, Macfarlane R, Britten N. Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ 1997;315:1211-14.
9. Hamm RM, Hicks RJ, Bemben DA. Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract 1996;43:56-62.
10. Lautenbach E, Strom BL, Nachamkin I, et al. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis 2004;38:655-62.
11. Norrby SR, Nord CE, Finch R. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 2005;5:115-19.
12. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 2004;38:1279-86.
13. Centers for Medicare and Medicaid Services. National health expenditure data. Table 3. Available from http://www.cms.hhs.gov/ NationalHealthExpendData/downloads/tables.pdf. Accessed January 12, 2007.
14. McCaig LF, Besser RE, Hughes JM. Antimicrobial drug prescription in ambulatory care settings, United States, 1992-2000. Emerg Infect Dis 2003;9:432-7.
15. Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989-1999. JAMA 2001;286:1181-6.
16. Oosterheert JJ, van Loon AM, Schuurman R, et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis 2005;41:1438-44.
17. Alvarez-Lerma F, Alvarez B, Luque P et al. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study. Crit Care 2006;10:1-11.
18. Bratzler DW, Houck PM, Richards C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the national surgical infection prevention project. Arch Surg 2005;140:174-82.
19. Struelens MJ. Multidisciplinary antimicrobial management teams: the way forward to control antimicrobial resistance in hospitals. Curr Opin Infect Dis 2003;16:305-7.
20. Evans RS, Lloyd JF, Abouzelof RH, et al. System-wide surveillance for clinical encounters by patients previously identified with MRSA and VRE. Medinfo 2004;11:212-16.
21. Fishman N. Antimicrobial stewardship. Am J Med 2006;119(6 suppl 1):S53-61.